News | March 06, 2023
Par Drugs and Chemicals receives WHO-GMP certificate
The audit was commenced for newly renovated manufacturing Block 1, Block 2, and Block 3
The audit was commenced for newly renovated manufacturing Block 1, Block 2, and Block 3
Vigabatrin for Oral Solution USP, 500 mg had annual sales of US $233.7 mn in US
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
Vigabatrin for Oral Solution USP, 500 mg had annual sales of USD 233.7 mn in the United States
This order is subject to initial advance payment as per the agreed terms of the contract and this order will be executed within 6 to 8 months.
he product will be launched shortly in the US market.
Apixaban Tablets, 2.5 mg and 5 mg had annual sales of USD 18,876 mn in the United States (IQVIA MAT Dec. 2022).
This combination medicine is used to treat high blood pressure (hypertension).
The company expects the GMP approval from Saudi Food and Drug Authority (SFDA) to soon pave the way for marketing authorizations from the largest market in the GCC region
Dr. Adams brings more than two decades of experience leading the manufacturing of biologic and gene therapies at all stages of development.
Subscribe To Our Newsletter & Stay Updated
